162327-73-3

Basic information

• Product Name: 5,6-Dichloro-N-methoxy-N-methylpyridine-3-carboxamide
• Synonyms: 5,6-Dichloro-N-methoxy-N-methylpyridine-3-carboxamide
• CAS NO: 162327-73-3
• Molecular Formula: C8H8Cl2N2O2
• Molecular Weight: 235.06732
• EINECS: 939-913-2
• Mol File: 162327-73-3.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5,6-Dichloro-N-methoxy-N-methylpyridine-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-Dichloro-N-methoxy-N-methylpyridine-3-carboxamide(162327-73-3)
• EPA Substance Registry System: 5,6-Dichloro-N-methoxy-N-methylpyridine-3-carboxamide(162327-73-3)

Safety Data

• Hazardous Substances Data: 162327-73-3(Hazardous Substances Data)

Upstream product

• 41667-95-2 5,6-dichloronicotinic acid 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 54127-29-6 5,6-dichloronicotinoyl chloride 

Downstream Products

• 71690-05-6 5,6-dichloro-pyridine-3-carbaldehyde 
• 1073616-37-1 (S)-N-(4-chloro-3-trifluoromethylphenyl)-4-(3-chloro-5-(1,2-dihydroxyethyl)pyridin-2-yl)piperazine-1-carboxamide 
• 1073616-26-8 (S)-3-chloro-5-(1,2-dihydroxyethyl)-3',6'-dihydro-2'H-[2,4']bipyridinyl-1'-carboxylic acid (3-chloro-4-trifluoromethylphenyl)amide 
• 1073616-33-7 (S)-4-(3-chloro-5-(1,2-dihydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethoxyphenyl)piperazine-1-carboxamide 
• 1073617-34-1 4-(3-chloro-5-(1,1-difluoro-2-hydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide 
• 1073616-35-9 (S)-4-(3-chloro-5-(1,2-dihydroxyethyl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)piperazine-1-carboxamide 
• 1073616-24-6 (S)-3-chloro-5-(1,2-dihydroxyethyl)-N-[4-(trifluoromethyl)phenyl]-3',6'-dihydro-(2,4'-bipyridine)-1'(2'H)-carboxamide 
• 1073616-38-2 4-(3-chloro-5-(1,3-dihydroxypropan-2-yl)pyridin-2-yl)-N-(4-trifluoromethylphenyl)-5,6-dihydropyridine-1(2H)-carboxamide 
• 1073616-32-6 (S)-N-(4-tert-butylphenyl)-4-(3-chloro-5-(1,2-dihydroxyethyl)pyridin-2-yl)piperazine-1-carboxamide 
• 71690-06-7 2,3-dichloro-5-(difluoromethyl)pyridine 
• 120800-05-7 2,3-dichloro-5-acetylpyridine 
• 1450622-25-9 (2S)-4-(2-(4-((6-amino-3-pyridinyl)sulfonyl)phenyl)-5-(2,2,2-trifluoro-1-hydroxy-1-mthylethyl)-3-pyridinyl)-3-butyn-2-ol 
• 1450622-21-5 (2R)-4-(2-(4-((6-amino-3-pyridinyl)sulfonyl)phenyl)-5-(2,2,2-trifluoro-1-hydroxy-1-methylethyl)-3-pyridinyl)-3-butyn-2-ol 
• 1450622-18-0 2-(6-(4-((6-amino-3-pyridinyl)sulfonyl)phenyl)-5-(cyclopropylethynyl)-3-pyridinyl)-1,1,1-trifluoro-2-propanol 

Relevant articles and documents

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceuticall acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising th

SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN

The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

BICYCLOHETEROARYL COMPOUNDS AND THEIR USE AS TRPV1 LIGANDS

The invention relates to compounds of formula I and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof.